本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Day One Biopharmaceuticals Inc.

7.19
+0.24003.45%
盘前7.390.2000+2.78%08:48 EDT
成交量:144.58万
成交额:1,040.13万
市值:7.29亿
市盈率:-10.12
高:7.33
开:7.09
低:7.02
收:6.95
数据加载中...
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/24

重要事件披露

Form 8-K - Current report
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities